Mesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur la microsimulation - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Disease Progression »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Disease Outbreaks < Disease Progression < Disease Transmission, Infectious  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000046 (2013) Tatiana Benaglia [Royaume-Uni] ; Linda D. Sharples ; Rebecca C. Fitzgerald ; Georgios LyratzopoulosHealth benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.
000082 (2012) Aukje Van Gestel [Pays-Bas] ; Janneke Grutters ; Jan Schouten ; Carroll Webers ; Henny Beckers ; Manuela Joore ; Johan SeverensThe role of the expected value of individualized care in cost-effectiveness analyses and decision making.
000088 (2012) Steven M. Kymes [États-Unis] ; Dennis L. Lambert ; Paul P. Lee ; David C. Musch ; Carla J. Siegfried ; Sameer V. Kotak ; Dustin L. Stwalley ; Joel Fain ; Chris Johnson ; Mae O. GordonThe development of a decision analytic model of changes in mean deviation in people with glaucoma: the COA model.
000102 (2012) Charles W. Drescher [États-Unis] ; Sarah Hawley ; Jason D. Thorpe ; Simone Marticke ; Martin Mcintosh ; Sanjiv S. Gambhir ; Nicole UrbanImpact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.
000105 (2012) Reto Kessler [Suisse] ; Gérald Keusch ; Thomas D. Szucs ; John S. Wittenborn ; Thomas J. Hoerger ; Urs Brügger ; Simon WieserHealth economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland.
000119 (2012) Pamela M. Mcmahon [États-Unis] ; Chung Yin Kong ; Bruce E. Johnson ; Milton C. Weinstein ; Jane C. Weeks ; Angela C. Tramontano ; Lauren E. Cipriano ; Colleen Bouzan ; G Scott GazelleChapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.
000126 (2011) Karen M. Kuntz [États-Unis] ; Iris Lansdorp-Vogelaar ; Carolyn M. Rutter ; Amy B. Knudsen ; Marjolein Van Ballegooijen ; James E. Savarino ; Eric J. Feuer ; Ann G. ZauberA systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression.
000169 (2010) Mickaël Hiligsmann [Belgique] ; Véronique Rabenda ; Henry-Jean Gathon ; Olivier Ethgen ; Jean-Yves ReginsterPotential clinical and economic impact of nonadherence with osteoporosis medications.
000179 (2010) Jeremy D. Goldhaber-Fiebert [États-Unis] ; Natasha K. Stout ; Sue J. GoldieEmpirically evaluating decision-analytic models.
000197 (2010) Thomas J. Hoerger [États-Unis] ; John S. Wittenborn ; Joel E. Segel ; Nilka R. Burrows ; Kumiko Imai ; Paul Eggers ; Meda E. Pavkov ; Regina Jordan ; Susan M. Hailpern ; Anton C. Schoolwerth ; Desmond E. WilliamsA health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.
000198 (2010) Thomas J. Hoerger [États-Unis] ; John S. Wittenborn ; Joel E. Segel ; Nilka R. Burrows ; Kumiko Imai ; Paul Eggers ; Meda E. Pavkov ; Regina Jordan ; Susan M. Hailpern ; Anton C. Schoolwerth ; Desmond E. WilliamsA health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.
000253 (2007) Görkem Saka [États-Unis] ; Jennifer E. Kreke ; Andrew J. Schaefer ; Chung-Chou H. Chang ; Mark S. Roberts ; Derek C. AngusUse of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis.
000270 (2007) Herwig Gerlach ; Susanne ToussaintBetween prediction, education, and quality control: simulation models in critical care.
000288 (2005) Oguzhan Alagoz [États-Unis] ; Cindy L. Bryce ; Steven Shechter ; Andrew Schaefer ; Chung-Chou H. Chang ; Derek C. Angus ; Mark S. RobertsIncorporating biological natural history in simulation models: empirical estimates of the progression of end-stage liver disease.
000300 (2005) Julia Kravchenko [États-Unis] ; Pascal J. Goldschmidt-Clermont ; Tiffany Powell ; Eric Stallard ; Igor Akushevich ; Michael S. Cuffe ; Kenneth G. MantonEndothelial progenitor cell therapy for atherosclerosis: the philosopher's stone for an aging population?
000377 (1995) W K Evans [Canada] ; B P Will ; J M Berthelot ; M C WolfsonEstimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=MicroSimulV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Disease Progression" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Disease Progression" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    MicroSimulV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Disease Progression
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sun Mar 10 17:35:57 2024. Site generation: Sun Mar 10 17:47:34 2024